Study Combining SAR245409 With Bendamustine and/or Rituximab in Subjects With Indolent Lymphoma, Mantle Cell Lymphoma & Chronic Lymphocytic Leukemia

This study is currently recruiting participants.

Verified January 2013 by Sanofi

Study NCT01410513 Information provided by Sanofi

First Received on July 26, 2011. Last Updated on January 28, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

SAR245409

Additional drug interventions recognized in this trial

Bendamustine
Rituximab

More general drug interventions related to this trial

Sponsors listed in this trial

Sanofi